The Nobel Prize in Chemistry was awarded this week to Emmanuelle Charpentier and Jennifer Doudna for the revolutionary CRISPR/Cas9 "genetic scissors" technology for genome editing. But is that analogy too limited for describing the true power and potential of CRISPR as a platform? And while the time between (unexpected) discovery to practice to award has been less than a decade, where are we, really, with CRISPR in practice?
Podden och tillhörande omslagsbild på den här sidan tillhör Andreessen Horowitz. Innehållet i podden är skapat av Andreessen Horowitz och inte av, eller tillsammans med, Poddtoppen.
